# Bionyra Pharma funding rounds and investors

As of 14 Oct 2026, Bionyra Pharma has raised $165M across 1 verified round on record; latest: $165 million Series A led by Jeito Capital and Sofinnova Partners, announced 22 Jun 2026.

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation biologics for severe immune-mediated inflammatory diseases.

Website: https://bionyra.com  
Headquarters: Paris & Boston  
Page: https://fireround.dev/companies/bionyra.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-06-22 | Series A | $165 million | Jeito Capital, Sofinnova Partners | Apollo Health Ventures, Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners | [businesswire.com](https://www.businesswire.com/news/home/20260622319137/en/Bionyra-Pharma-Launches-with-%24165-million-Oversubscribed-Series-A-to-Advance-Clinical-Stage-Pipeline-of-Next-Generation-Biologics-for-Immune-Mediated-Inflammatory-Diseases) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.